Pediatric pharmacology in the first year of life

Current Opinion in Anaesthesiology

Volumn 22, Issue 4, 2009, Pages 469-475

  Sumpter, Anita ^a   Anderson, Brian J ^b  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Maturation; Pharmacodynamics; Pharmacogenetics; Pharmacokinetics

Indexed keywords

ACICLOVIR; ANESTHETIC AGENT; APROTININ; BUPIVACAINE; CLONIDINE; DEXMEDETOMIDINE; FENTANYL; GLUCURONIDE; MERCAPTOPURINE; MIDAZOLAM; MILRINONE; MORPHINE; PARACETAMOL; PROPOFOL; REMIFENTANIL; TRAMADOL; VANCOMYCIN;

ALLOMETRY; ANESTHESIA; ATRIOVENTRICULAR BLOCK; BODY COMPOSITION; BODY SURFACE; BODY WEIGHT; BRADYCARDIA; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATION; CONSTIPATION; CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG EXCRETION; DRUG MEGADOSE; DRUG METABOLISM; DRUG MONITORING; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIVER TOXICITY; MATURATION; NEWBORN PERIOD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; PHARMACOGENOMICS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETAMINOPHEN; AGE FACTORS; APROTININ; BASAL METABOLISM; ELECTROENCEPHALOGRAPHY; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; MODELS, BIOLOGICAL; PHARMACOGENETICS; PHARMACOKINETICS; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 68949114216     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32832bc7ff     Document Type: Review

References (50)

1. Johnson TN. The problems in scaling adult drug doses to children. Arch Dis. Child 2008; 93:207-211.
2. Johnson TN, Rostami-Hodjegan A, Tucker GT. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin Pharmacokinet 2006; 45:931-956.
3. Edginton AN, Schmitt W, Voith B, Willmann S. A mechanistic approach for the scaling of clearance in children. Clin Pharmacokinet 2006; 45:683-704.
4. Edginton AN, Theil FP, Schmitt W, Willmann S. Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol 2008; 4:1143-1152.
5. Tod M, Jullien V, Pons G. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008; 47:231-243.
6. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48:303-332.
7. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 1910; 14:iv-vii.
8. Richards FJ. A flexible growth function for empirical use. J Exp Bot 1959; 10:290-301.
9. Allegaert K, Anderson BJ, Verbesselt R, et al. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P450 2D6 activity. Br J Anaesth 2005; 95:231-239.
10. Tod M, Lokiec F, Bidault R, et al. Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis. Antimicrob Agents Chemother 2001; 45:150-157.
11. Potts AL, Larsson P, Eksborg S, et al. Clonidine disposition in children; a population analysis. Pediatr Anesth 2007; 17:924-933.
12. Hawwa AF, Collier PS, Millership JS, et al. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia. Br J Clin Pharmacol 2008; 66:826-837.
13. Allegaert K, Peeters MY, Verbesselt R, et al. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth 2007; 99:864-870.
14. Rigby-Jones AE, Priston MJ, Sneyd JR, et al. Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. Br J Anaesth 2007; 99:252-261.
15. Anderson BJ, Allegaert K, Van den Anker JN, et al. Vancomycin pharmaco-kinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2007; 63:75-84.
16. Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009; 24:25-36.
17. Anand KJ, Anderson BJ, Holford NH, et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. Br J Anaesth 2008; 101:680-689.
18. Potts AL, Warman GR, Anderson BJ. Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth 2008; 18:722-730.
19. Allegaert K, de Hoon J, Verbesselt R, et al. Maturational pharmacokinetics of single intravenous bolus of propofol. Paediatr Anaesth 2007; 17:1028-1034.
20. Rhodin MM, Anderson BJ, Peters AM, etal. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009; 24:67-76.
21. Paradisis M, Jiang X, McLachlan AJ, et al. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch Dis Child Fetal Neonatal Ed 2007; 92:F204-F209.
22. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349:1157-1167.
23. Palmer GM, Atkins M, Anderson BJ, et al. I.V. acetaminophen pharmacoki-netics in neonates after multiple doses. Br J Anaesth 2008; 101:523-530.
24. Koch SC, Fitzgerald M, Hathway GJ. Midazolam potentiates nociceptive behavior, sensitizes cutaneous reflexes, and is devoid of sedative action in neonatal rats. Anesthesiology 2008; 108:122-129.
25. Tobin JR. Paradoxical effects of midazolam in the very young. Anesthesiology 2008; 108:6-7.
26. Huang GH, Davidson AJ, Stargatt R. Dreaming during anaesthesia in children: incidence, nature and associations. Anaesthesia 2005; 60:854-861.
27. Engelhardt T, Petroz GC, McCheyne A, Bissonnette B. Awareness during pediatric anesthesia: what is the position of European pediatric anesthesiologists? Paediatr Anaesth 2007; 17:1066-1070.
28. Davidson AJ, Wong A, Knottenbelt G, et al. MAC-awake of sevoflurane in children. Paediatr Anaesth 2008; 18:702-707.
29. Wallenborn J, Kluba K, Olthoff D. Comparative evaluation of Bispectral Index and Narcotrend Index in children below 5 years of age. Paediatr Anaesth 2007; 17:140-147.
30. Lamas A, Lopez-Herce J, Sancho L, et al. Bispectral index and middle latency auditory evoked potentials in children younger than two-years-old. Anesth Analg 2008; 106:426-432.
31. Davidson AJ, Sale SM, Wong C, et al. The electroencephalograph during anesthesia and emergence in infants and children. Paediatr Anaesth 2008;18:60-70.
32. Jeleazcov C, Schmidt J, Schmitz B, et al. EEG variables as measures of arousal during propofol anaesthesia for general surgery in children: rational selection and age dependence. Br J Anaesth 2007; 99:845-854.
33. Freye E. Development of sensory information processing: the ontogenesis of opioid binding sites in nociceptive afferents and their significance in the clinical setting. Acta Anaesthesiol Scand Suppl 1996; 109:98-101.
34. Allegaert K, van den Anker JN, de Hoon JN, et al. Covariates of tramadol disposition in the first months of life. Br J Anaesth 2008; 100:525-532.
35. Palmer GM, Chen SP, Smith KR, Hardikar W. Introduction and audit of intravenous paracetamol at a tertiary paediatric teaching hospital. Anaesth Intensive Care 2007; 35:702-706.
36. Allegaert K, Rayyan M, De Rijdt T, et al. Hepatic tolerance of repeated intravenous paracetamol administration in neonates. Paediatr Anaesth 2008; 18:388-392.
37. Agrawal S, Fitzsimons JJ, Horn V, Petros A. Intravenous paracetamol for postoperative analgesia in a 4-day-old term neonate. Paediatr Anaesth 2007; 17:70-71.
38. Allegaert K, Murat I, Anderson BJ. Not all intravenous paracetamol formulations are created equal. Paediatr Anaesth 2007; 17:811-812.
39. Bartocci M, Lundeberg S. Intravenous paracetamol: the 'Stockholm protocol' for postoperative analgesia of term and preterm neonates. Paediatr Anaesth 2007; 17:1120-1121.
40. Walls L, Baker CF, Sarkar S. Acetaminophen-induced hepatic failure with encephalopathy in a newborn. J Perinatol 2007; 27:133-135.
41. Krumbiegel P, Domke S, Morseburg B, et al. Maturation of hepatosomal mono-oxygenation and glucuronidation activities in pre and full-term infants as studied using the [15N]methacetin urine test. Acta Paediatr 1997; 86:1236-1240.
42. Prins SA, Van Dijk M, Van Leeuwen P, et al. Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery. Paediatr Anaesth 2008; 18:582-592.
43. Pohl-Schickinger A, Lemmer J, Hubler M, et al. Intravenous clonidine infusion in infants after cardiovascular surgery. Paediatr Anaesth 2008; 18:217-222.
44. Mason KP, Zgleszewski SE, Prescilla R, et al. Hemodynamic effects of dexmedetomidine sedation for CT imaging studies. Paediatr Anaesth 2008; 18:393-402.
45. Mason KP, Zurakowski D, Zgleszewski SE, etal. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth 2008; 18:403-411.
46. Hammer GB, Drover DR, Cao H, et al. The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth Analg 2008; 106:79-83.
47. Twite MD, Hammer GB. The use of aprotinin in pediatric cardiac surgery: should we bid 'good riddance' or are we throwing out the baby with the bath water? Paediatr Anaesth 2008; 18:809-811.
48. Szekely A, Sapi E, Breuer T, et al. Aprotinin and renal dysfunction after pediatric cardiac surgery. Paediatr Anaesth 2008; 18:151-159.
49. Chiravuri SD, Voepel-Lewis T, Devaney EJ, Malviya S. The use of aprotinin in children undergoing operative repair of isolated atrial septal defects. Paediatr Anaesth 2008; 18:145-150.
50. Williams GD, Ramamoorthy C, Pentcheva K, et al. A randomized, controlled •• trial of aprotinin in neonates undergoing open-heart surgery. Paediatr Anaesth 2008; 18:812-819.